Related Experiment Videos
[Immunologic study of lymphoproliferative diseases]
M E Cabrera1, A Majlis, S Labra
1Departamento de Medicina (División Cs M Oriente) Universidad de Chile, Santiago.
Revista Medica De Chile
|July 1, 1992
Summary
Immunophenotyping using monoclonal antibodies is a valuable diagnostic tool for B- and T-cell lymphoproliferative diseases. This method aids in classifying these cancers for more targeted patient treatments.
Area of Science:
- Hematology
- Immunology
- Oncology
Context:
- Lymphoproliferative diseases (LPDs) encompass a heterogeneous group of malignancies affecting lymphocytes.
- Accurate classification of B-cell LPDs (BLD) and T-cell LPDs (TLD) is crucial for effective management.
- Traditional diagnostic methods like cytology and histopathology can be complemented by immunophenotyping.
Purpose:
- To evaluate the utility of monoclonal antibody-based immunophenotyping in diagnosing and classifying stage IV lymphoproliferative diseases.
- To identify common antigen expression patterns in BLD and TLD.
- To assess the diagnostic value of immunophenotyping alongside conventional methods.
Summary:
- Thirty-six patients with stage IV LPDs (26 BLD, 10 TLD) were analyzed using a panel of monoclonal antibodies.
- Common antigens in BLD included HLA-DR and CD19 (B4), while CD4+CD8+ was prevalent in TLD.
- Immunophenotyping, combined with cytology and histopathology, helps define distinct pathological groups for tailored therapies.
Impact:
- Immunophenotyping provides essential diagnostic information for lymphoproliferative diseases.
- This technique enhances the ability to differentiate between B-cell and T-cell malignancies.
- Improved diagnostic accuracy facilitates more specific and effective treatment strategies for patients with LPDs.